Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Insulin-Dependent, 12

Explore clinical trials studying Diabetes Mellitus, Insulin-Dependent, 12. Study availability and eligibility vary by location and protocol.

55 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Insulin-Dependent, 12 trial results

Completed

A Study of a Personalized Neoantigen Cancer Vaccine

NCT03639714

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

NCT03953235

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +26 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Santa Monica, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • University of Chicago Medicine, Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details
Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.

NCT03084471

Conditions
Advanced Solid Malignancies, Diabetes Mellitus, Insulin-Dependent, 12
Locations
  • Research Site Santa Rosa, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Tinley Park, Illinois, United States
  • Research Site Omaha, Nebraska, United States
View all 79 locations
View Trial Details
Completed

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

NCT01896869

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions